178 related articles for article (PubMed ID: 18853343)
1. Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.
Roman-Blas JA; Jimenez SA
Int Rev Immunol; 2008; 27(5):351-74. PubMed ID: 18853343
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.
Roman-Blas JA; Jimenez SA
Osteoarthritis Cartilage; 2006 Sep; 14(9):839-48. PubMed ID: 16730463
[TBL] [Abstract][Full Text] [Related]
3. Can NF-kappaB be a target for novel and efficient anti-cancer agents?
Olivier S; Robe P; Bours V
Biochem Pharmacol; 2006 Oct; 72(9):1054-68. PubMed ID: 16973133
[TBL] [Abstract][Full Text] [Related]
4. From willow bark to peptides: the ever widening spectrum of NF-kappaB inhibitors.
D'Acquisto F; Ianaro A
Curr Opin Pharmacol; 2006 Aug; 6(4):387-92. PubMed ID: 16781194
[TBL] [Abstract][Full Text] [Related]
5. NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?
Haddad JJ; Abdel-Karim NE
Cell Immunol; 2011; 271(1):5-14. PubMed ID: 21777910
[TBL] [Abstract][Full Text] [Related]
6. NF-kappaB modulators in osteolytic bone diseases.
Xu J; Wu HF; Ang ES; Yip K; Woloszyn M; Zheng MH; Tan RX
Cytokine Growth Factor Rev; 2009 Feb; 20(1):7-17. PubMed ID: 19046922
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
8. Hypoxic regulation of NF-kappaB signaling.
Cummins EP; Comerford KM; Scholz C; Bruning U; Taylor CT
Methods Enzymol; 2007; 435():479-92. PubMed ID: 17998070
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks.
Uwe S
Biochem Pharmacol; 2008 Apr; 75(8):1567-79. PubMed ID: 18070616
[TBL] [Abstract][Full Text] [Related]
10. A novel technique for selective NF-kappaB inhibition in Kupffer cells: contrary effects in fulminant hepatitis and ischaemia-reperfusion.
Hoffmann F; Sass G; Zillies J; Zahler S; Tiegs G; Hartkorn A; Fuchs S; Wagner J; Winter G; Coester C; Gerbes AL; Vollmar AM
Gut; 2009 Dec; 58(12):1670-8. PubMed ID: 19470497
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor kappaB signaling in atherogenesis.
de Winther MP; Kanters E; Kraal G; Hofker MH
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):904-14. PubMed ID: 15731497
[TBL] [Abstract][Full Text] [Related]
12. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities.
Surh YJ
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():269-72. PubMed ID: 18296353
[TBL] [Abstract][Full Text] [Related]
13. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis.
Wang H; Syrovets T; Kess D; Büchele B; Hainzl H; Lunov O; Weiss JM; Scharffetter-Kochanek K; Simmet T
J Immunol; 2009 Oct; 183(7):4755-63. PubMed ID: 19752240
[TBL] [Abstract][Full Text] [Related]
14. Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.
Wilczynski J; Duechler M; Czyz M
Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):289-99. PubMed ID: 21625848
[TBL] [Abstract][Full Text] [Related]
15. Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro.
Haddad JJ
Mol Immunol; 2009 Dec; 47(2-3):205-14. PubMed ID: 19850345
[TBL] [Abstract][Full Text] [Related]
16. A novel, highly selective, tight binding IkappaB kinase-2 (IKK-2) inhibitor: a tool to correlate IKK-2 activity to the fate and functions of the components of the nuclear factor-kappaB pathway in arthritis-relevant cells and animal models.
Mbalaviele G; Sommers CD; Bonar SL; Mathialagan S; Schindler JF; Guzova JA; Shaffer AF; Melton MA; Christine LJ; Tripp CS; Chiang PC; Thompson DC; Hu Y; Kishore N
J Pharmacol Exp Ther; 2009 Apr; 329(1):14-25. PubMed ID: 19168710
[TBL] [Abstract][Full Text] [Related]
17. Transcription factors.
Handel ML; Girgis L
Best Pract Res Clin Rheumatol; 2001 Dec; 15(5):657-75. PubMed ID: 11812014
[TBL] [Abstract][Full Text] [Related]
18. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle diseases, inflammation, and NF-kappaB signaling: insights and opportunities for therapeutic intervention.
Peterson JM; Guttridge DC
Int Rev Immunol; 2008; 27(5):375-87. PubMed ID: 18853344
[TBL] [Abstract][Full Text] [Related]
20. Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde?
Noort AR; Tak PP; Tas SW
Arthritis Res Ther; 2015 Jan; 17(1):15. PubMed ID: 25774937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
